JPS6254403B2 - - Google Patents

Info

Publication number
JPS6254403B2
JPS6254403B2 JP57160728A JP16072882A JPS6254403B2 JP S6254403 B2 JPS6254403 B2 JP S6254403B2 JP 57160728 A JP57160728 A JP 57160728A JP 16072882 A JP16072882 A JP 16072882A JP S6254403 B2 JPS6254403 B2 JP S6254403B2
Authority
JP
Japan
Prior art keywords
htp
oxytryptophan
inosine
water
complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP57160728A
Other languages
English (en)
Japanese (ja)
Other versions
JPS58109417A (ja
Inventor
Raruieru Kuroodo
Rupan Maruseru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PANMEDEIKA SA
Original Assignee
PANMEDEIKA SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PANMEDEIKA SA filed Critical PANMEDEIKA SA
Publication of JPS58109417A publication Critical patent/JPS58109417A/ja
Publication of JPS6254403B2 publication Critical patent/JPS6254403B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Indole Compounds (AREA)
JP57160728A 1981-09-16 1982-09-14 セロトニンの代謝欠之を補正するための新規な薬剤 Granted JPS58109417A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR8117492 1981-09-16
FR8117492A FR2512672A1 (fr) 1981-09-16 1981-09-16 Nouvelles compositions a base de 5-hydroxytryptophane, leur procede de preparation et medicaments les contenant
FR8213980 1982-08-11

Publications (2)

Publication Number Publication Date
JPS58109417A JPS58109417A (ja) 1983-06-29
JPS6254403B2 true JPS6254403B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1987-11-14

Family

ID=9262193

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57160728A Granted JPS58109417A (ja) 1981-09-16 1982-09-14 セロトニンの代謝欠之を補正するための新規な薬剤

Country Status (3)

Country Link
JP (1) JPS58109417A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2512672A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA826752B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2928386B2 (ja) * 1992-07-08 1999-08-03 協和醗酵工業株式会社 うつ病治療剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1601066A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1966-06-18 1970-08-10
ES376906A1 (es) * 1970-02-25 1973-02-01 Made Labor Sa Un metodo de obtencion de alfa-cetoglutarato de piridoxina y 5-hidroxitriptofano.
GB1535778A (en) * 1976-12-06 1978-12-13 Mac Sweeney D Compounds useful in treatment of unipolar depression
DE2841170A1 (de) * 1978-09-21 1980-04-03 Pharmazeutische Praeparate Apo Hypnotikum

Also Published As

Publication number Publication date
FR2512672A1 (fr) 1983-03-18
ZA826752B (en) 1983-07-27
FR2512672B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1984-02-24
JPS58109417A (ja) 1983-06-29

Similar Documents

Publication Publication Date Title
RU2118317C1 (ru) (-)-[[4-(1,4,5,6-тетрагидро-4-метил-6-оксо-3-пиридазинил)фенил]гидразоно]пропандинитрил и его фармацевтически приемлемые соли, фармацевтическая композиция на его основе, способ получения промежуточного соединения и способ получения целевого соединения
CA2832483A1 (en) Methods and compositions for treating neurodegenerative diseases
EP2694066A1 (en) Methods and compositions for treating parkinson's disease
EP3675858A2 (en) Compounds and compositions for ire1 inhibition
CN105451741A (zh) 布鲁顿酪氨酸激酶的抑制剂
JP2020535196A (ja) Ａ２ａ受容体アンタゴニストとしての縮合環誘導体
US4472387A (en) Pharmaceutical compositions capable of increasing cerebral serotonin concentration
EP3738961A1 (en) Heterocyclic compound as csf-1r inhibitor and use thereof
JP3937367B2 (ja) 一酸化窒素合成酵素阻害剤
EP3134390B1 (en) Small molecule inhibitors of g protein coupled receptor 6 kinase polypeptides
WO1993017023A1 (fr) Derives de pyrazolopyrimidines antagonistes des recepteurs a l'angiotensine ii
JPS6254403B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP7026852B2 (ja) チアジアゾール誘導体及びｇｌｓ１阻害剤としてのその使用
HU187626B (en) Process for preparing vincamine saccharinate
JP2019522651A (ja) タンパク質キナーゼ阻害剤としての置換されているピロロ［２，３−ｄ］ピリダジン−４−オン及びピラゾロ［３，４−ｄ］ピリダジン−４−オン
KR20140123513A (ko) 탄소환 뉴클레오시드 및 이들의 약학적 용도 및 조성물
KR20180020119A (ko) 새로운 5형포스포디에스테라아제 억제제 및 그 용도
JP2020523369A (ja) Ｇｌｓ１阻害剤としての化合物
CN115894376B (zh) 一种芳香族酰胺类化合物、药物组合物及其用途
US20230322725A1 (en) Inhibitors for the b-catenin/b-cell lymphoma 9 (bcl9) protein-protein interaction
US4418062A (en) Amino derivatives of chloro nitro amino pyrazines useful as adjuncts to radiation therapy
FR2877005A1 (fr) Nouveaux derives d'arylpiperazine
FR2460950A1 (fr) Nouvelles 4-phenyl-4,5,6,7-tetrahydropyrrolo(2,3-c)pyridines, procede pour leur preparation et medicaments les renfermant
HK40044836B (en) Thiadiazole derivative and use thereof as a gls1 inhibitor
HK40044836A (en) Thiadiazole derivative and use thereof as a gls1 inhibitor